Prostate CancerAPROPOSNCT04501055
Anesthesia in PROstate Biopsy Pain Obstruction Study
A study testing perineal nerve block and periprostatic block in people with Prostate Cancer, run by Shanghai East Hospital at 1 site in China.
Trial summary
This is a multicentre randomized controlled trial in comparison of the perineal nerve block approach between the periprostatic block in the pain control in men undergo a transperineal prostate biopsy. Read more about this study
- Who is it for?
- Ages 18 to 80 years, men onlyHealthy volunteers can take part
- Conditions the study is for
- Prostate Cancer
- What is being tested?
- perineal nerve block and periprostatic block
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 192 participants
- Where
- 1 siteChina
- Study dates
- 13 Aug 2020to 27 Jul 2022
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 80 years
- Men only
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- age between 18 and 80 years old
- a PSA level of 4 - 20 ng/ml, and/or suspicious rectal examination findings;
- fully understand the clinical trial protocol and sign the informed consent;
Who cannot join
- local anesthetic allergy patients;
- symptomatic acute or chronic inflammation of the prostate;
- cannot tolerate prostate biopsy or has contraindication to biopsy;
- patients judged by the investigator to be unsuitable to participate in the clinical trial;
Trial locations and contacts
1 site in 1 country.
China1 site
Shanghai East Hospital, Tongji University School of Medicine
Shanghai, Shanghai Municipality, 200120
About this study
Official title: A Prospective Multicenter Randomized Controlled Trial Assessing Whether the Perineal Nerve Block Approach is Better Than the Periprostatic Block for the Pain Control in Men Who Undergo Transperineal Prostate Biopsy
This is a multicentre randomized controlled trial in comparison of the perineal nerve block approach between the periprostatic block in the pain control in men undergo a transperineal prostate biopsy.
Read the detailed description
This trial is a prospective, multicentre, randomized controlled study in which all men plan to undergo a transperineal prostate biopsy. This study aims to determine whether the perineal nerve block approach is better than the periprostatic block in the pain control in men undergo a transperineal prostate biopsy.
- Conditions
- Prostate Cancer
- Being tested
- perineal nerve block, periprostatic block
- Keywords
- Prostate Cancer, transperineal prostate biopsy, perineal nerve block, periprostatic block, anesthesia
- Medical subject headings
- Prostatic Neoplasms
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
perineal nerve blockBehavioural
An anesthesia method to block perineal nerve
periprostatic blockBehavioural
An anesthesia method to block periprostate
| Study group | Role | What they receive |
|---|---|---|
| Perineal nerve block | Experimental | Man receive the perineal nerve block before under the transperineal prostate biopsy Receives: Behavioral: perineal nerve block |
| Periprostatic block | Active comparator | Man receive the periprostatic block before under the transperineal prostate biopsy Receives: Behavioral: periprostatic block |
What is being measured
The primary outcome is the main question the study is designed to answer.
The pain of the biopsy procedure
The pain will be measured by numerical rating scale(NRS), which distributed from 0 to 10. 0 represents no pain, and 10 represents the worst pain imaginable.
Measured: within10 minutes after the prostate biopsy
Secondary outcomes (12)
The pain in 1,6, and 12 hours after the biopsy
The pain in 1,6, and 12 hours will be measured by numerical rating scale(NRS), which distributed from 0 to 10. 0 represents no pain, and 10 represents the worst pain imaginable.
Measured: 1,6, and 12 hours after the biopsy
Changes in blood pressure during biopsy procedure
The changes will be measured and recorded by multi-parameter monitoring
Measured: During the biopsy procedure
Changes in heart rate during biopsy procedure
The changes will be measured and recorded by multi-parameter monitoring
Measured: During the biopsy procedure
Changes in breath rate during biopsy procedure
The changes will be measured and recorded by multi-parameter monitoring
Measured: During the biopsy procedure
The detection rate for prostate cancer
The detection rate for any of the prostate cancer
Measured: within 1 month after the biopsy
The detection rate for clinically significant prostate cancer
The detection rate for prostate cancer with a ISUP>2
Measured: within 1 month after the biopsy
External manifestation of pain
A questionnaire with five items: the degree of facial expression (0 for no particular expression or smile; 1 for an occasional grimace or frown, a withdrawn expression, or a disinterested expression; 2 for frequent or constant quivering chin or a clenched jaw), the degree of activity (0 for lying quietly or being in a normal position, 1 for slight contractions of the hip muscles or slight movements of hip, 2 for severe contractions of the hip or lifting the hip out of the bed), the degree of voice expression (0 for quiet or normal communication, 1 for an occasional moan or weeping sound, 2 for constant moaning or sobbing and screaming), the degree of pacification (0 for being peaceful and not requiring pacification, 1 for being able to be comforted easily, 2 for being difficult to comfort) and the degree of cooperation (0 for being calm and cooperative, 1 for language resistance, 2 for body resistance).
Measured: 10 minutes within biopsy
Anaesthesia satisfaction
A questionnaire with five items :whether the pain during the biopsy was less severe than expected (scores from 0 to 10, where 0 represents far less severe and 10 represents far more severe than expected); whether the pain after anaesthesia was less severe than the pain during anaesthesia (scores from 0 to 10, where 0 represents far less severe and 10 represents far more severe); weather the patient is satisfied with the overall feeling of the biopsy (scores from 0 to 10, where 0 represents the highest level of satisfaction and 10 represents the lowest level of satisfaction); whether the patient would recommend this type of biopsy to other patients (scores from 0 to 10, where 0 represents they would highly recommend it and 10 represents they would definitely not recommend it); and whether the patient would still want to choose this way if they have to undergo another biopsy (scores from 0 to 10, where 0 represents very willing to choose it and 10 represents extreme reluctance).
Measured: 24 hours after the biopsy
Adverse event
Any of the adverse events during the trial
Measured: Within 1 week after the biopsy
The number of biopsy cores
The number of biopsy cores
Measured: 10 minutes within biopsy
The location of each biopsy core
The location of each biopsy core
Measured: 10 minutes within biopsy
Prostate volume
The prostate volume will be measured by MRI before biopsy
Measured: within 3 months before the biopsy procedure
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted6 Aug 2020
- Study start13 Aug 2020
- Primary completion20 Jul 2022
- Study completion27 Jul 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (2)Papers the sponsor has linked to this study.
- Other trials for Prostate CancerStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Triple blind
- Who is masked
- Participant, Investigator, Outcomes assessor
- Enrolment
- 192 participants (actual)
Sponsor and investigators
- Lead sponsor
- Shanghai East Hospital
- Sponsor type
- University, hospital or other
- Collaborators
- Shi Shi Municipal General Hospital, People's Hospital of Yiyuan County, The First Affiliated Hospital of University of Science and Technology of China, Guang'an people's hospital of Sichuan province, Chinese University of Hong Kong, Chongqing Medical University
- Responsible party
- Sponsor
- Investigators
- Haifeng Wang, Principal investigator, Shanghai East Hospital of Tongji University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04501055
- Sponsor's protocol ID
- APROPOS-01
- Acronym
- APROPOS
- Status last verified
- Oct 2022
- First submitted
- 29 Jul 2020
- Last updated
- 28 Oct 2022
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: Once available, the results of this trial will be disseminated to an international peer-reviewed journal and presentations at international or national academic conferences. The data will be made available upon request to researchers a) who provide a methodologically sound proposal and b) whose proposed use of the data has been approved by an independent ethical review committee.
Publications
He BM, Ka-Fung Chiu P, Tao T, Lan JH, Cai JT, Zhou SC, Li RB, Ren Y, Ka-Lun LO, Xu RY, Chen JR, Lan D, Gao JL, Chu SG, Jin ZC, Huang FF, Shi ZK, Yang QW, Zhou H, Wang SD, Ji TR, Han QP, Wang CM, Chi-Fai NG, Wang HF; APROPOS Group. Perineal nerve block versus periprostatic block for patients undergoing transperineal prostate biopsy (APROPOS): a prospective, multicentre, randomised controlled study. EClinicalMedicine. 2023 Mar 23;58:101919. doi: 10.1016/j.eclinm.2023.101919. eCollection 2023 Apr.
PubMed 37007736He BM, Li RB, Wang HF. Anaesthesia in PROstate Biopsy Pain Obstruction Study: A Study Protocol for a Multicentre Randomised Controlled Study Evaluating the Efficacy of Perineal Nerve Block in Controlling Pain in Patients Undergoing Transperineal Prostate Biopsy. Front Surg. 2021 Oct 6;8:649822. doi: 10.3389/fsurg.2021.649822. eCollection 2021.
PubMed 34692757
Study at a glance
From the registry record, last updated by the sponsor on 28 Oct 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Prospective Multicenter Randomized Controlled Trial Assessing Whether the Perineal Nerve Block Approach is Better Than the Periprostatic Block for the Pain Control in Men Who Undergo Transperineal Prostate Biopsy
- ClinicalTrials.gov ID
- NCT04501055
- Acronym / sponsor ID
- APROPOS / APROPOS-01
- Conditions
- Prostate Cancer
- Keywords
- Prostate Cancer, transperineal prostate biopsy, perineal nerve block, periprostatic block, anesthesia
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 192 participants (actual)
- Lead sponsor
- Shanghai East HospitalUniversity, hospital or other
- Collaborators
- Shi Shi Municipal General Hospital, People's Hospital of Yiyuan County, The First Affiliated Hospital of University of Science and Technology of China, Guang'an people's hospital of Sichuan province, Chinese University of Hong Kong, Chongqing Medical University
- Study start
- 13 Aug 2020 (actual)
- Primary completion
- 20 Jul 2022 (actual)
- Study completion
- 27 Jul 2022 (actual)
- First posted
- 6 Aug 2020 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This is a multicentre randomized controlled trial in comparison of the perineal nerve block approach between the periprostatic block in the pain control in men undergo a transperineal prostate biopsy.
Detailed description
This trial is a prospective, multicentre, randomized controlled study in which all men plan to undergo a transperineal prostate biopsy. This study aims to determine whether the perineal nerve block approach is better than the periprostatic block in the pain control in men undergo a transperineal prostate biopsy.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Triple blind (participant, investigator, outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Perineal nerve block | Experimental | Behavioral: perineal nerve blockMan receive the perineal nerve block before under the transperineal prostate biopsy |
| Periprostatic block | Active comparator | Behavioral: periprostatic blockMan receive the periprostatic block before under the transperineal prostate biopsy |
Who may qualify
- Ages
- 18 to 80 years
- Sex
- Male only
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- age between 18 and 80 years old
- a PSA level of 4 - 20 ng/ml, and/or suspicious rectal examination findings;
- fully understand the clinical trial protocol and sign the informed consent;
Key exclusion criteria (4 listed)
- local anesthetic allergy patients;
- symptomatic acute or chronic inflammation of the prostate;
- cannot tolerate prostate biopsy or has contraindication to biopsy;
- patients judged by the investigator to be unsuitable to participate in the clinical trial;
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| perineal nerve blockAn anesthesia method to block perineal nerve | Behavioural | Perineal nerve block |
| periprostatic blockAn anesthesia method to block periprostate | Behavioural | Periprostatic block |
Primary outcome
The pain of the biopsy procedure
Time frame: within10 minutes after the prostate biopsy
The pain will be measured by numerical rating scale(NRS), which distributed from 0 to 10. 0 represents no pain, and 10 represents the worst pain imaginable.
12 secondary outcomes
The pain in 1,6, and 12 hours after the biopsy
Time frame: 1,6, and 12 hours after the biopsy
Changes in blood pressure during biopsy procedure
Time frame: During the biopsy procedure
Changes in heart rate during biopsy procedure
Time frame: During the biopsy procedure
Changes in breath rate during biopsy procedure
Time frame: During the biopsy procedure
The detection rate for prostate cancer
Time frame: within 1 month after the biopsy
The detection rate for clinically significant prostate cancer
Time frame: within 1 month after the biopsy
External manifestation of pain
Time frame: 10 minutes within biopsy
Anaesthesia satisfaction
Time frame: 24 hours after the biopsy
Adverse event
Time frame: Within 1 week after the biopsy
The number of biopsy cores
Time frame: 10 minutes within biopsy
The location of each biopsy core
Time frame: 10 minutes within biopsy
Prostate volume
Time frame: within 3 months before the biopsy procedure
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 28 Oct 2022.
- Derived from this study: PubMed 37007736He BM, Ka-Fung Chiu P, Tao T, Lan JH, Cai JT, Zhou SC, Li RB, Ren Y, Ka-Lun LO, Xu RY, Chen JR, Lan D, Gao JL, Chu SG, Jin ZC, Huang FF, Shi ZK, Yang QW, Zhou H, Wang SD, Ji TR, Han QP, Wang CM, Chi-Fai NG, Wang HF; APROPOS Group. Perineal nerve block versus periprostatic block for patients undergoing transperineal prostate biopsy (APROPOS): a prospective, multicentre, randomised controlled study. EClinicalMedicine. 2023 Mar 23;58:101919. doi: 10.1016/j.eclinm.2023.101919. eCollection 2023 Apr.
- Derived from this study: PubMed 34692757He BM, Li RB, Wang HF. Anaesthesia in PROstate Biopsy Pain Obstruction Study: A Study Protocol for a Multicentre Randomised Controlled Study Evaluating the Efficacy of Perineal Nerve Block in Controlling Pain in Patients Undergoing Transperineal Prostate Biopsy. Front Surg. 2021 Oct 6;8:649822. doi: 10.3389/fsurg.2021.649822. eCollection 2021.
- Individual participant dataSharing planned: Yes. Once available, the results of this trial will be disseminated to an international peer-reviewed journal and presentations at international or national academic conferences. The data will be made available upon request to researchers a) who provide a methodologically sound proposal and b) whose proposed use of the data has been approved by an independent ethical review committee.
Related trials for Prostate Cancer
Active, not recruitingPhase 2
Hormone Therapy and Intensity-Modulated Radiation Therapy in Treating Patients With Metastatic Prostate Cancer
PSA Level Greater Than Two, Stage IV Prostate Adenocarcinoma AJCC v7
RecruitingEarly Phase 1
FTT PET/CT in Metastatic Prostate Cancer
Prostate Cancer Metastatic
Enrolling by invitation
Use of Tracking Devices to Locate Abnormalities During Invasive Procedures
Adenocarcinoma, Prostate Neoplasms
RecruitingPhase 2
Terbinafine for Biochemically Recurrent Prostate Cancer (TerbinaPro)
Recurrent Prostate Cancer
RecruitingPhase 1/2
Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors
Liposarcoma, Prostate Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Haifeng Wang principal investigator
Shanghai East Hospital of Tongji University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing perineal nerve block and periprostatic block in people with Prostate Cancer, run by Shanghai East Hospital at 1 site in China.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 28 Oct 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
The pain of the biopsy procedure (time frame: within10 minutes after the prostate biopsy). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT04501055, which also lists 2 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Oct 2022.